| Abatacept |
L04 |
Immunosuppressants |
0.4% |
✓ |
|
✓ |
| Acamprosate |
N07 |
Other nervous system drugs |
<0.1% |
✓ |
|
|
| Acarbose |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Acebutolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Acenocoumarol |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
| Acetazolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Acetylcysteine |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
| Acitretin |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
| Aclidinium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Acyclovir |
J05 |
Antivirals for systemic use |
0.1% |
|
✓ |
|
| Adalimumab |
L04 |
Immunosuppressants |
3.3% |
✓ |
|
✓ |
| Adapalene |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
| Adapalene, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
| Adefovir dipivoxil |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
| Alendronic acid |
M05 |
Drugs for treatment of bone diseases |
0.1% |
|
✓ |
|
| Alendronic acid and cholecalciferol |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
| Alfa-1 antitrypsin |
B02 |
Antihemorrhagics |
0.1% |
✓ |
|
✓ |
| Alfuzosin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Alimemazine |
R06 |
Antihistamines for systemic use |
<0.1% |
✓ |
|
|
| Aliskiren fumarate |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Alitretinoin |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
| Allopurinol |
M04 |
Antigout preparations |
0.1% |
|
✓ |
|
| Almotriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Alogliptin benzoate |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Alogliptin benzoate and metformin HCl |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Alprazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Alprostadil |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
| Amantadine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Ambrisentan |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
| Amcinonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Amfetamine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Amikacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Amiloride |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Amiodarone |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Amitriptyline |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
| Amlodipine |
C08 |
Calcium channel blockers |
1.0% |
|
✓ |
|
| Amoxicillin |
J01 |
Antibacterials for systemic use |
0.3% |
|
✓ |
|
| Amoxicillin and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Amphotericin B |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
|
| Ampicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Anakinra |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
✓ |
| Anethole trithione |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
| Antihypertensives for pulmonary arterial hypertension |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Antiinfectives, combinations |
S03 |
Ophthalmological and otological preparations |
<0.1% |
|
✓ |
|
| Antispasmodics in combination with other drugs |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Apixaban |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
| Apraclonidine |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Apremilast |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
| Aprepitant |
A04 |
Antiemetics and antinauseants |
<0.1% |
✓ |
|
|
| Aripiprazole |
N05 |
Psycholeptics |
0.8% |
✓ |
|
|
| Asanepine |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
| Atenolol |
C07 |
Beta blocking agents |
0.2% |
|
✓ |
|
| Atenolol and other diuretics |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Atomoxetine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Atorvastatin |
C10 |
Lipid modifying agents |
1.8% |
|
✓ |
|
| Atorvastatin and amlodipine |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
| Atovaquone |
P01 |
Antiprotozoals |
<0.1% |
✓ |
|
|
| Atropine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Auranofin |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
✓ |
|
|
| Azathioprine |
L04 |
Immunosuppressants |
<0.1% |
|
✓ |
|
| Azelaic acid |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
| Azilsartan medoxomil |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Azithromycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Aztreonam |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
✓ |
| Bacitracin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Baclofen |
M03 |
Muscle relaxants |
0.1% |
|
✓ |
|
| Beclometasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Beclomethasone |
R01 |
Nasal preparations |
<0.1% |
|
✓ |
|
| Benazepril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Benzathine benzylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Benzatropine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Benzoyl peroxide |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
| Benzylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Betahistine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Betaine |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
| Betamethasone |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.1% |
|
✓ |
|
| Betamethasone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Betamethasone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Betaxolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Bethanechol |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Bezafibrate |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
| Bimatoprost |
S01 |
Ophthalmologicals |
0.4% |
✓ |
|
|
| Bismuth preparations |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Bisoprolol |
C07 |
Beta blocking agents |
0.1% |
|
✓ |
|
| Boceprevir |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
✓ |
| Bosentan |
C02 |
Antihypertensives |
0.2% |
|
✓ |
|
| Botulinum toxin |
M03 |
Muscle relaxants |
0.5% |
✓ |
|
|
| Brimonidine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Brinzolamide |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Brinzolamide, combinations |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Bromazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Bromocriptine |
G02 |
Other gynecologicals |
<0.1% |
|
✓ |
|
| Budesonide |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.2% |
|
✓ |
|
| Bumetanide |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
| Bupivacaine |
N01 |
Anesthetics |
<0.1% |
✓ |
|
|
| Buprenorphine, combinations |
N07 |
Other nervous system drugs |
0.2% |
|
✓ |
|
| Bupropion |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
| Buserelin |
L02 |
Endocrine therapy |
<0.1% |
✓ |
|
|
| Buspirone |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Butorphanol |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Butylscopolamine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Cabergoline |
G02 |
Other gynecologicals |
<0.1% |
|
✓ |
|
| Calcipotriol |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
| Calcipotriol, combinations |
D05 |
Antipsoriatics |
0.2% |
✓ |
|
|
| Calcitonin (salmon synthetic) |
H05 |
Calcium homeostasis |
<0.1% |
|
✓ |
|
| Calcium folinate |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
| Canagliflozin |
A10 |
Drugs used in diabetes |
0.1% |
✓ |
|
|
| Candersartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Candesartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
| Captopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Carbamazepine |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
| Carvedilol |
C07 |
Beta blocking agents |
0.1% |
|
✓ |
|
| Cefaclor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefadroxil |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefalexin |
J01 |
Antibacterials for systemic use |
0.2% |
|
✓ |
|
| Cefazolin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefixime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefotaxime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefprozil |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Ceftazidime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Ceftriaxone |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Cefuroxime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Celecoxib |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
| Certolizumab pegol |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
| Cetirizine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
| Cetrorelix acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
| Chloral hydrate |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Chloramphenicol |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Chlordiazepoxide |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Chloroquine |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
| Chlorpromazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Chlorpropamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Chlortalidone |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Chlorzoxazone, combinations excluding psycholeptics |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
| Choline theophyllinate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Ciclesonide |
R03 |
Drugs for obstructive airway diseases |
0.3% |
✓ |
|
|
| Ciclopirox |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
| Ciclosporin |
L04 |
Immunosuppressants |
0.2% |
|
✓ |
|
| Cilazapril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Cilazapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Cimetidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
| Cinacalcet |
H05 |
Calcium homeostasis |
<0.1% |
✓ |
|
|
| Ciprofloxacin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Citalopram |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
| Clarithromycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Clidinium and psycholeptics |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Clindamycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Clindamycin, combinations |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
| Clobazam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Clobetasol |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Clobetasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
| Clodronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
✓ |
|
|
| Clomifene |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Clomipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Clonazepam |
N03 |
Antiepileptics |
0.1% |
|
✓ |
|
| Clonidine |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Clopidogrel |
B01 |
Antithrombotic agents |
0.5% |
|
✓ |
|
| Clorazepate potassium |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Clotrimazole |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
| Cloxacillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Clozapine |
N05 |
Psycholeptics |
0.3% |
|
✓ |
|
| Codeine, combinations with psycholeptics |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Codeine |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
| Codeine, combinations excluding psycholeptics |
N02 |
Analgesics |
0.3% |
|
✓ |
|
| Colchicine |
M04 |
Antigout preparations |
<0.1% |
|
✓ |
|
| Colesevelam |
C10 |
Lipid modifying agents |
<0.1% |
✓ |
|
|
| Colestipol |
C10 |
Lipid modifying agents |
<0.1% |
✓ |
|
|
| Colestyramine |
C10 |
Lipid modifying agents |
0.1% |
|
✓ |
|
| Colistin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Collagenase |
D03 |
Preparations for treatment of wounds and ulcers |
<0.1% |
✓ |
|
|
| Conjugated estrogens |
G03 |
Sex hormones and modulators of the genital system |
0.1% |
|
✓ |
|
| Cortisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
| Cromoglicic acid |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Cyclobenzaprine |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
| Cyclopentolate |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Cyproterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Cyproterone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Dabigatran etexilate |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
| Dalteparin |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
| Danazol |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Dantrolene |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
| Dapagliflozin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Dapsone |
J04 |
Antimycobacterials |
<0.1% |
|
✓ |
|
| Daptomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Darifenacin |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
| Dasabuvir, ombitasvir, paritaprevir and ritonavir |
J05 |
Antivirals for systemic use |
0.1% |
✓ |
|
✓ |
| Deferasirox |
V03 |
All other therapeutic products |
0.2% |
✓ |
|
✓ |
| Deferoxamine |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
| Denosumab |
M05 |
Drugs for treatment of bone diseases |
0.6% |
✓ |
|
|
| Desipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Desmopressin |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
|
✓ |
|
| Desogestrel and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Desonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Desoximetasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Dexamethasone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
| Dexamethasone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Dexamfetamine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
| Dexlansoprazole |
A02 |
Drugs for acid related disorders |
<0.1% |
✓ |
|
|
| Diazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Diazoxide |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
| Diclofenac |
M01 |
Antiinflammatory and antirheumatic products |
0.1% |
|
✓ |
|
| Diclofenac, combinations |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
| Dicycloverine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Dienogest |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Diflucortolone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
| Digoxin |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Dihydroergotamine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Diltiazem |
C08 |
Calcium channel blockers |
0.7% |
|
✓ |
|
| Dimethyl fumarate |
N07 |
Other nervous system drugs |
0.5% |
✓ |
|
|
| Dimethyl sulfoxide |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Diphenhydramine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
| Diphenoxylate |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Dipyridamole |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
| Disopyramide |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
| Domperidone |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Donepezil |
N06 |
Psychoanaleptics |
0.4% |
|
✓ |
|
| Dornase alfa (desoxyribonuclease) |
R05 |
Cough and cold preparations |
<0.1% |
✓ |
|
|
| Dorzolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Doxazosin |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Doxepin |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Doxycycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Doxylamine, combinations |
R06 |
Antihistamines for systemic use |
0.1% |
✓ |
|
|
| Dronedarone |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
| Drospirenone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Duloxetine |
N06 |
Psychoanaleptics |
1.5% |
✓ |
|
|
| Dutasteride |
G04 |
Urologicals |
0.2% |
|
✓ |
|
| Eculizumab |
L04 |
Immunosuppressants |
0.3% |
✓ |
|
✓ |
| Eletriptan |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Eltrombopag |
B02 |
Antihemorrhagics |
<0.1% |
✓ |
|
✓ |
| Enalapril |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
| Enalapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Enoxaparin |
B01 |
Antithrombotic agents |
0.2% |
|
✓ |
|
| Entacapone |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Entecavir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
| Epinephrine |
C01 |
Cardiac therapy |
0.2% |
|
✓ |
|
| Eplerenone |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
| Epoprostenol |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
✓ |
| Eprosartan |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Eprosartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Ergoloid mesylates |
C04 |
Peripheral vasodilators |
<0.1% |
|
✓ |
|
| Ergotamine, combinations excluding psycholeptics |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Ertapenem |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Erythromycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Erythromycin, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
| Escitalopram |
N06 |
Psychoanaleptics |
0.4% |
|
✓ |
|
| Eslicarbazepine |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Esomeprazole |
A02 |
Drugs for acid related disorders |
0.2% |
|
✓ |
|
| Estradiol |
G03 |
Sex hormones and modulators of the genital system |
0.3% |
|
✓ |
|
| Estrone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Etacrynic acid |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Etanercept |
L04 |
Immunosuppressants |
2.2% |
✓ |
|
✓ |
| Ethosuximide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Etidronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
| Etidronic acid and calcium, sequential |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
| Etodolac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Etynodiol and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Ezetimibe |
C10 |
Lipid modifying agents |
0.3% |
|
✓ |
|
| Famciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
| Famotidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
| Febuxostat |
M04 |
Antigout preparations |
<0.1% |
✓ |
|
|
| Felodipine |
C08 |
Calcium channel blockers |
0.2% |
|
✓ |
|
| Fenofibrate |
C10 |
Lipid modifying agents |
0.2% |
|
✓ |
|
| Fenoterol and ipratropium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Fentanyl |
N01 |
Anesthetics |
0.4% |
|
✓ |
|
| Fesoterodine |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
| Fidaxomicin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Filgrastim |
L03 |
Immunostimulants |
0.7% |
✓ |
|
|
| Finasteride |
G04 |
Urologicals |
0.1% |
|
✓ |
|
| Fingolimod |
L04 |
Immunosuppressants |
0.3% |
✓ |
|
✓ |
| Flecainide |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Fluconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
|
✓ |
|
| Fludrocortisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
✓ |
|
|
| Flumetasone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
| Flumetasone and antiinfectives |
S02 |
Otologicals |
<0.1% |
✓ |
|
|
| Flunarizine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Flunisolide |
R01 |
Nasal preparations |
<0.1% |
|
✓ |
|
| Fluocinolone acetonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Fluocinonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Fluorometholone |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Fluoxetine |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
| Flupentixol |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Fluphenazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Flurazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Flurbiprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Fluticasone |
R03 |
Drugs for obstructive airway diseases |
0.9% |
|
✓ |
|
| Fluticasone furoate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Fluvastatin |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
| Fluvoxamine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Follitropin alfa |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Follitropin beta |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Fondaparinux |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
| Formoterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Formoterol and budesonide |
R03 |
Drugs for obstructive airway diseases |
1.1% |
✓ |
|
|
| Formoterol and mometasone |
R03 |
Drugs for obstructive airway diseases |
0.1% |
✓ |
|
|
| Fosfomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Fosinopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Framycetin |
D09 |
Medicated dressings |
<0.1% |
✓ |
|
|
| Furosemide |
C03 |
Diuretics |
0.2% |
|
✓ |
|
| Fusidic acid |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
0.1% |
|
✓ |
|
| Gabapentin |
N03 |
Antiepileptics |
0.7% |
|
✓ |
|
| Galantamine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
| Ganciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
|
| Ganirelix acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
| Gatifloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Gemfibrozil |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
| Gentamicin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Glatiramer acetate |
L03 |
Immunostimulants |
0.5% |
✓ |
|
✓ |
| Glibenclamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Gliclazide |
A10 |
Drugs used in diabetes |
0.3% |
|
✓ |
|
| Glimepiride |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Glucagon |
H04 |
Pancreatic hormones |
<0.1% |
✓ |
|
|
| Glyceryl trinitrate |
C01 |
Cardiac therapy |
0.2% |
|
✓ |
|
| Glycopyrronium |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Glycopyrronium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Golimumab |
L04 |
Immunosuppressants |
0.5% |
✓ |
|
✓ |
| Gonadorelin acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
| Gonadotrophine chorionique |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Goserelin |
L02 |
Endocrine therapy |
0.3% |
✓ |
|
|
| Granisetron |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
| Griseofulvin |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
| Guanfacine HCl |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
| Haloperidol |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Heparin |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
| Hexachlorophene |
D08 |
Antiseptics and disinfectants |
<0.1% |
✓ |
|
|
| Homatropine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Hydralazine |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Hydrochlorothiazide |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Hydrochlorothiazide and potassium-sparing agents |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Hydrocodone |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
| Hydrocortisone |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.2% |
|
✓ |
|
| Hydrocortisone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Hydrocortisone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Hydrocortisone, combinations |
C05 |
Vasoprotectives |
<0.1% |
|
✓ |
|
| Hydromorphone |
N02 |
Analgesics |
1.2% |
|
✓ |
|
| Hydroxychloroquine |
P01 |
Antiprotozoals |
0.1% |
|
✓ |
|
| Hydroxyquinoline derivatives |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
| Hydroxyzine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Ibuprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Imidazoles/triazoles in combination with corticosteroids |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
| Imipenem and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Imipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Imiquimod |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
| Indacaterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Indacaterol and glycopyrronium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Indapamide |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Indometacin |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Infliximab |
L04 |
Immunosuppressants |
5.1% |
✓ |
|
✓ |
| Insulin (human) |
A10 |
Drugs used in diabetes |
0.7% |
|
✓ |
|
| Insulin (pork) |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Insulin aspart |
A10 |
Drugs used in diabetes |
0.7% |
✓ |
|
|
| Insulin detemir |
A10 |
Drugs used in diabetes |
0.5% |
✓ |
|
|
| Insulin glargine |
A10 |
Drugs used in diabetes |
1.8% |
✓ |
|
|
| Insulin glulisine |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Insulin lispro |
A10 |
Drugs used in diabetes |
0.6% |
✓ |
|
|
| Interferon alfa-2b |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
| Interferon beta-1a |
L03 |
Immunostimulants |
0.6% |
✓ |
|
✓ |
| Interferon beta-1b |
L03 |
Immunostimulants |
0.1% |
✓ |
|
✓ |
| Ipratropium bromide |
R01 |
Nasal preparations |
0.2% |
|
✓ |
|
| Irbesartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
| Irbesartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Isosorbide dinitrate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Isosorbide mononitrate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Isotretinoin |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
| Itraconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
|
| Ivacaftor |
R07 |
Other respiratory system products |
0.2% |
✓ |
|
✓ |
| Ketoconazole |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
| Ketoprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Ketorolac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Ketotifen |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
| Labetalol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Lacosamide |
N03 |
Antiepileptics |
0.1% |
✓ |
|
|
| Lactic acid producing organisms |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Lamivudine |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
| Lamotrigine |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
| Lanreotide |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
✓ |
| Lansoprazole |
A02 |
Drugs for acid related disorders |
0.4% |
|
✓ |
|
| Lansoprazole, amoxicillin and clarithromycin |
A02 |
Drugs for acid related disorders |
<0.1% |
✓ |
|
|
| Lanthanum carbonate |
V03 |
All other therapeutic products |
<0.1% |
✓ |
|
|
| Latanoprost |
S01 |
Ophthalmologicals |
0.1% |
|
✓ |
|
| Leflunomide |
L04 |
Immunosuppressants |
0.1% |
|
✓ |
|
| Leuprorelin |
L02 |
Endocrine therapy |
0.5% |
✓ |
|
|
| Levetiracetam |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
| Levobunolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Levocarnitine |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
| Levodopa and decarboxylase inhibitor |
N04 |
Anti-Parkinson drugs |
0.4% |
|
✓ |
|
| Levodopa, decarboxylase inhibitor, and COMT inhibitor |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
| Levofloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Levomepromazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Levonorgestrel and estrogen |
G03 |
Sex hormones and modulators of the genital system |
0.2% |
|
✓ |
|
| Levothyroxine sodium |
H03 |
Thyroid therapy |
0.4% |
|
✓ |
|
| Lidocaine |
D04 |
Antipruritics, incl. Antihistamines, anesthetics, etc. |
<0.1% |
|
✓ |
|
| Linagliptin |
A10 |
Drugs used in diabetes |
0.4% |
✓ |
|
|
| Lincomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Linezolid |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Liothyronine sodium |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
| Liraglutide |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Lisdexamfetamine |
N06 |
Psychoanaleptics |
0.2% |
✓ |
|
|
| Lisinopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Lisinopril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Lithium |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Lodoxamide |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Loperamide |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Lorazepam |
N05 |
Psycholeptics |
0.1% |
|
✓ |
|
| Losartan |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
| Losartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Lovastatin |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
| Loxapine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Lurasidone |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
| Macitentan |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
| Mebendazole |
P02 |
Anthelmintics |
<0.1% |
✓ |
|
|
| Medroxyprogesterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Mefenamic acid |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Mefloquine HCl |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
| Megestrol |
L02 |
Endocrine therapy |
<0.1% |
|
✓ |
|
| Meloxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Memantine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Meropenem |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Mesalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.6% |
|
✓ |
|
| Mesuximide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Metformin |
A10 |
Drugs used in diabetes |
0.5% |
|
✓ |
|
| Metformin and linagliptin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Metformin and rosiglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Metformin and saxagliptin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Metformin and sitagliptin |
A10 |
Drugs used in diabetes |
1.0% |
✓ |
|
|
| Methadone |
N07 |
Other nervous system drugs |
0.3% |
|
✓ |
|
| Methazolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Methenamine |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Methocarbamol, combinations excluding psycholeptics |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
| Methoxalen, topical |
D05 |
Antipsoriatics |
<0.1% |
|
✓ |
|
| Methyldopa (racemic) |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Methylphenidate |
N06 |
Psychoanaleptics |
0.5% |
|
✓ |
|
| Methylprednisolone |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
| Methylprednisolone, combinations |
H02 |
Corticosteroids for systemic use |
<0.1% |
✓ |
|
|
| Metoclopramide |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Metolazone |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
| Metoprolol |
C07 |
Beta blocking agents |
0.3% |
|
✓ |
|
| Metronidazole |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
| Mexiletine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Miconazole |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
| Midazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Midodrine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Milrinone lactate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Minocycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Minoxidil |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
| Mirtazapine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
| Misoprostol |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
| Moclobemide |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Modafinil |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Mometasone |
D07 |
Corticosteroids, dermatological preparations |
0.2% |
|
✓ |
|
| Montelukast |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Morphine |
N02 |
Analgesics |
0.4% |
|
✓ |
|
| Moxifloxacin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Multienzymes (lipase, protease etc.) |
A09 |
Digestives, incl. Enzymes |
0.2% |
✓ |
|
|
| Mycophenolic acid |
L04 |
Immunosuppressants |
0.3% |
|
✓ |
|
| Nabilone |
A04 |
Antiemetics and antinauseants |
0.2% |
|
✓ |
|
| Nabumetone |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Nadolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Nadroparin |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
| Nafarelin |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
| Naltrexone |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Naproxen |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
| Naratriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Natalizumab |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
| Nateglinide |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Nedocromil |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Neomycin |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
| Neostigmine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Nepafenac |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Nicotinic acid |
C04 |
Peripheral vasodilators |
<0.1% |
✓ |
|
|
| Nifedipine |
C08 |
Calcium channel blockers |
0.9% |
|
✓ |
|
| Nimodipine |
C08 |
Calcium channel blockers |
<0.1% |
✓ |
|
|
| Nitrazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Nitrofurantoin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Nizatidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
| Norelgestromin and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Norethisterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Norethisterone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Norfloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Norgestimate and estrogen |
G03 |
Sex hormones and modulators of the genital system |
0.2% |
|
✓ |
|
| Nortriptyline |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
| Nystatin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Nystatin, combinations |
G01 |
Gynecological antiinfectives and antiseptics |
<0.1% |
✓ |
|
|
| Ocriplasmin |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Octreotide |
H01 |
Pituitary and hypothalamic hormones and analogues |
0.5% |
|
✓ |
|
| Ofloxacin |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Olanzapine |
N05 |
Psycholeptics |
0.5% |
|
✓ |
|
| Olmesartan medoxomil |
C09 |
Agents acting on the renin-angiotensin system |
0.3% |
✓ |
|
|
| Olmesartan medoxomil and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
✓ |
|
|
| Olopatadine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Olsalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Omalizumab |
R03 |
Drugs for obstructive airway diseases |
0.2% |
✓ |
|
✓ |
| Omeprazole |
A02 |
Drugs for acid related disorders |
0.5% |
|
✓ |
|
| Ondansetron |
A04 |
Antiemetics and antinauseants |
0.2% |
|
✓ |
|
| Opium |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Opium derivatives and expectorants |
R05 |
Cough and cold preparations |
<0.1% |
✓ |
|
|
| Oral rehydration salt formulations |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Orciprenaline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Orlistat |
A08 |
Antiobesity preparations, excl. Diet products |
<0.1% |
✓ |
|
|
| Orphenadrine (citrate) |
M03 |
Muscle relaxants |
<0.1% |
✓ |
|
|
| Other aminoglycosides |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
| Other antiemetics |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
| Oxazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Oxcarbazepine |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
| Oxybutynin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Oxycodone |
N02 |
Analgesics |
0.5% |
|
✓ |
|
| Oxycodone, combinations |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Paliperidone |
N05 |
Psycholeptics |
0.9% |
✓ |
|
|
| Pamidronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
| Pantoprazole |
A02 |
Drugs for acid related disorders |
1.9% |
|
✓ |
|
| Papaverine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Paraldehyde |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Paromomycin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Paroxetine |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
| Pegfilgrastim |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
✓ |
| Peginterferon alfa-2a |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
| Peginterferon alfa-2a, combinations |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
| Peginterferon alfa-2b, combinations |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
| Penicillamine |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Pentamidine isethionate |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
| Pentazocine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Pentostan polysulfate sodium |
C05 |
Vasoprotectives |
<0.1% |
✓ |
|
|
| Pentoxifylline |
C04 |
Peripheral vasodilators |
<0.1% |
|
✓ |
|
| Perampanel |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Periciazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Perindopril |
C09 |
Agents acting on the renin-angiotensin system |
1.5% |
|
✓ |
|
| Perindopril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.5% |
✓ |
|
|
| Perphenazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Pethidine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Phenelzine |
N06 |
Psychoanaleptics |
<0.1% |
✓ |
|
|
| Phenobarbital |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
| Phenoxymethylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Phenylephrine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Phenytoin |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
| Phosphodiesterase inhibitors |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Phytomenadione |
B02 |
Antihemorrhagics |
<0.1% |
|
✓ |
|
| Pilocarpine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Pimecrolimus |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
| Pimozide |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Pinaverium |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
✓ |
|
|
| Pindolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Pindolol and other diuretics |
C07 |
Beta blocking agents |
<0.1% |
✓ |
|
|
| Pioglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Piperacillin and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Pipotiazine |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
| Piroxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Pizotifen |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Plastic IUD with progestogens |
G02 |
Other gynecologicals |
0.2% |
✓ |
|
|
| Plerixafor |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
✓ |
| Podophyllotoxin |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
✓ |
|
|
| Polystyrene sulphonate |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
| Posaconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
✓ |
| Pramipexole |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Prasugrel |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
| Pravastatin |
C10 |
Lipid modifying agents |
0.2% |
|
✓ |
|
| Praziquantel |
P02 |
Anthelmintics |
<0.1% |
✓ |
|
|
| Prazosin |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
| Prednisolone |
H02 |
Corticosteroids for systemic use |
0.1% |
|
✓ |
|
| Prednisolone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Prednisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
| Pregabalin |
N03 |
Antiepileptics |
0.3% |
|
✓ |
|
| Primaquine |
P01 |
Antiprotozoals |
<0.1% |
✓ |
|
|
| Primidone |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
| Probenecid |
M04 |
Antigout preparations |
<0.1% |
✓ |
|
|
| Prochlorperazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Procyclidine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Profenamine |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
| Progesterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Promethazine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
| Propafenone |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Propranolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Propylthiouracil |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
| Protease inhibitors |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
✓ |
| Proxymetacaine |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
| Pyridostigmine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Quetiapine |
N05 |
Psycholeptics |
0.7% |
|
✓ |
|
| Quinagolide |
G02 |
Other gynecologicals |
<0.1% |
✓ |
|
|
| Quinapril |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
| Quinapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Quinidine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
| Quinine |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
| Rabeprazole |
A02 |
Drugs for acid related disorders |
0.5% |
|
✓ |
|
| Raloxifene |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
| Ramipril |
C09 |
Agents acting on the renin-angiotensin system |
0.7% |
|
✓ |
|
| Ramipril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Ranitidine |
A02 |
Drugs for acid related disorders |
0.3% |
|
✓ |
|
| Rasagiline |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
| Repaglinide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Ribavirin |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
|
| Rifaximin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
| Riluzole |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Riociguat |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
| Risedronic acid |
M05 |
Drugs for treatment of bone diseases |
0.7% |
|
✓ |
|
| Risperidone |
N05 |
Psycholeptics |
0.7% |
|
✓ |
|
| Rivaroxaban |
B01 |
Antithrombotic agents |
1.0% |
✓ |
|
|
| Rivastigmine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Rizatriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Romiplostim |
B02 |
Antihemorrhagics |
<0.1% |
✓ |
|
✓ |
| Ropinirole |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Rosiglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
| Rosuvastatin |
C10 |
Lipid modifying agents |
1.3% |
|
✓ |
|
| Rufinamide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Salbutamol |
R03 |
Drugs for obstructive airway diseases |
0.4% |
|
✓ |
|
| Salbutamol and ipratropium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Salmeterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Salmeterol and fluticasone |
R03 |
Drugs for obstructive airway diseases |
2.4% |
✓ |
|
|
| Sapropterin |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
✓ |
| Saxagliptin |
A10 |
Drugs used in diabetes |
0.3% |
✓ |
|
|
| Scopolamine |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
| Secukinumab |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
| Selegiline |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Sertraline |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
| Sevelamer |
V03 |
All other therapeutic products |
<0.1% |
✓ |
|
|
| Sildenafil |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Silodosin |
G04 |
Urologicals |
0.2% |
✓ |
|
|
| Silver sulfadiazine |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
| Simvastatin |
C10 |
Lipid modifying agents |
0.4% |
|
✓ |
|
| Sirolimus |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
| Sitagliptin |
A10 |
Drugs used in diabetes |
1.3% |
✓ |
|
|
| Sodium aurothiomalate |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Sodium tetradecyl sulphate |
C05 |
Vasoprotectives |
<0.1% |
|
✓ |
|
| Sofosbuvir |
J05 |
Antivirals for systemic use |
1.3% |
✓ |
|
✓ |
| Sofosbuvir and ledipasvir |
J05 |
Antivirals for systemic use |
5.2% |
✓ |
|
✓ |
| Solifenacin |
G04 |
Urologicals |
0.2% |
|
✓ |
|
| Somatropin |
H01 |
Pituitary and hypothalamic hormones and analogues |
0.2% |
✓ |
|
✓ |
| Sotalol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
| Spiramycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Spironolactone |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
| Stiripentol |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Sucralfate |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
| Sufentanil |
N01 |
Anesthetics |
<0.1% |
|
✓ |
|
| Sulfamethoxazole |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Sulfamethoxazole and trimethoprim |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Sulfasalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Sulfinpyrazone |
M04 |
Antigout preparations |
<0.1% |
|
✓ |
|
| Sulindac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Sulphur, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
| Sumatriptan |
N02 |
Analgesics |
0.1% |
|
✓ |
|
| Tacrolimus |
D11 |
Other dermatological preparations |
0.4% |
|
✓ |
|
| Tamsulosin |
G04 |
Urologicals |
0.2% |
|
✓ |
|
| Tazarotene |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
| Telmisartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
| Telmisartan and amlodipine |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Telmisartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
| Temazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Tenofovir disoproxil |
J05 |
Antivirals for systemic use |
0.5% |
✓ |
|
|
| Tenoxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Terazosin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Terbinafine |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
| Terbutaline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Terconazole |
G01 |
Gynecological antiinfectives and antiseptics |
<0.1% |
|
✓ |
|
| Teriflunomide |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
| Teriparatide |
H05 |
Calcium homeostasis |
<0.1% |
✓ |
|
|
| Testosterone |
G03 |
Sex hormones and modulators of the genital system |
0.1% |
|
✓ |
|
| Tetrabenazine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
| Tetracosactide |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
✓ |
| Tetracycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Theophylline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Theophylline, combinations excluding psycholeptics |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
| Thiamazole |
H03 |
Thyroid therapy |
<0.1% |
|
|
|
| Thioridazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Thyroid gland preparations |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
| Thyrotrophin |
V04 |
Diagnostic agents |
<0.1% |
✓ |
|
|
| Tiaprofenic acid |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
| Ticagrelor |
B01 |
Antithrombotic agents |
0.1% |
✓ |
|
|
| Ticlopidine |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
| Tigecycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Timolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Timolol, combinations |
S01 |
Ophthalmologicals |
0.5% |
|
✓ |
|
| Tinzaparin |
B01 |
Antithrombotic agents |
0.2% |
✓ |
|
|
| Tiotixene |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
| Tiotropium bromide |
R03 |
Drugs for obstructive airway diseases |
1.5% |
✓ |
|
|
| Tizanidine |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
| Tobramycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
| Tocilizumab |
L04 |
Immunosuppressants |
0.2% |
✓ |
|
✓ |
| Tofacitinib |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
| Tolbutamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
| Tolterodine |
G04 |
Urologicals |
0.3% |
|
✓ |
|
| Topiramate |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
| Trandolapril |
C09 |
Agents acting on the renin-angiotensin system |
0.3% |
✓ |
|
|
| Trandolapril and verapamil HCl |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
| Tranexamic acid |
B02 |
Antihemorrhagics |
<0.1% |
|
✓ |
|
| Tranylcypromine |
N06 |
Psychoanaleptics |
<0.1% |
✓ |
|
|
| Travoprost |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Trazodone |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Treprostinil |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
✓ |
| Tretinoin |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
| Triamcinolone |
A01 |
Stomatological preparations |
<0.1% |
|
✓ |
|
| Triamcinolone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
| Triazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Trifluoperazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
| Trifluridine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Trihexyphenidyl |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
| Trimebutine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
| Trimethoprim |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
| Trimipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Triptorelin |
L02 |
Endocrine therapy |
<0.1% |
✓ |
|
|
| Tropicamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
| Trospium |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
| Tryptophan |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
| Ulipristal |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Ulobetasol |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
| Urinary antispasmodics |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
| Urinary concrement solvents |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Urofollitropin |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
| Ursodeoxycholic acid |
A05 |
Bile and liver therapy |
0.1% |
|
✓ |
|
| Ustekinumab |
L04 |
Immunosuppressants |
0.5% |
✓ |
|
✓ |
| Vaginal ring with progestogen and estrogen |
G02 |
Other gynecologicals |
<0.1% |
✓ |
|
|
| Valaciclovir |
J05 |
Antivirals for systemic use |
0.5% |
|
✓ |
|
| Valganciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
| Valproic acid |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
| Valsartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
| Valsartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
| Vancomycin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
| Varenicline |
N07 |
Other nervous system drugs |
0.2% |
✓ |
|
|
| Venlafaxine |
N06 |
Psychoanaleptics |
0.5% |
|
✓ |
|
| Verapamil |
C08 |
Calcium channel blockers |
<0.1% |
|
✓ |
|
| Vigabatrin |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
| Vilanterol and fluticasone furoate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Vilanterol and umeclidinium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Voriconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
|
✓ |
|
| Warfarin |
B01 |
Antithrombotic agents |
0.2% |
|
✓ |
|
| Wart and anti-corn preparations |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
| Yohimbin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
| Zafirlukast |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
| Ziprasidone |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
| Zoledronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
| Zolmitriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
| Zopiclone |
N05 |
Psycholeptics |
0.2% |
|
✓ |
|
| Zuclopenthixol |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|